Sancilio Pharmaceuticals Company, Inc. is a Riviera Beach, Florida-based pharmaceutical development and manufacturing enterprise. The company utilizes its proprietary Advanced Lipid Technologies platform to develop prescription medicines, including Altemia for pediatric sickle cell disease, alongside a pipeline targeting hypertriglyceridemia and other disorders. It also markets Ocean Blue omega-3 supplements, prenatal and dental health products, and provides third-party manufacturing services. The firm employs 97 full-time staff.
